Literature DB >> 18383154

Color-coded duplex ultrasound for diagnosis of renal artery stenosis and as follow-up examination after revascularization.

Thomas Zeller1, Robert F Bonvini, Sebastian Sixt.   

Abstract

Currently, angiography is still considered to be the gold standard for the diagnosis of a renal artery stenosis (RAS). However, angiography is invasive and carries the potential risk of haematoma, pseudoaneurysm, contrast agent induced nephropathy, and athermanous embolization. Color-coded duplex ultrasound is a noninvasive frequently repeatable bed-side examination and is currently the only diagnostic method to reliably differentiate between a hemodynamically relevant or irrelevant stenosis using the side-to-side difference of the intrarenal resistance index (RI). There is a highly specific correlation between a side difference of the RI of >0.05 and an at least 70% angiographic diameter stenosis. All other duplex parameters like a peak systolic flow velocity >200 cm/sec or a renal aortic flow velocity ratio >3.5 are correlated to a 50 or 60% angiographic diameter stenosis and offer therefore indeed a high sensitivity in terms of detecting a RAS; however, the specificity detecting a hemodynamically relevant RAS is low. Provided that duplex ultrasound is performed by an experienced physician with an adequate machine it should be the preferred imaging method. The present article gives an overview about the literature related to duplex based diagnosis of RAS and as a follow-up diagnostic procedure following RAS revascularization. 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18383154     DOI: 10.1002/ccd.21525

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  10 in total

Review 1.  Renovascular hypertension: screening and modern management.

Authors:  Iris Baumgartner; Lilach O Lerman
Journal:  Eur Heart J       Date:  2011-01-27       Impact factor: 29.983

Review 2.  Diagnostic criteria for renovascular disease: where are we now?

Authors:  Sandra M S Herrmann; Stephen C Textor
Journal:  Nephrol Dial Transplant       Date:  2012-07       Impact factor: 5.992

3.  Unrecognized secondary causes of hypertension in patients with hypertensive urgency/emergency: prevalence and co-prevalence.

Authors:  Jan Börgel; Stephanie Springer; Jasmin Ghafoor; Daniel Arndt; Hans-Werner Duchna; Andreas Barthel; Sibylle Werner; Josef Van Helden; Christoph Hanefeld; Horst Neubauer; Daniel Bulut; Andreas Mügge
Journal:  Clin Res Cardiol       Date:  2010-04-02       Impact factor: 5.460

Review 4.  [Hypertension in patients with renal artery stenosis].

Authors:  A Voiculescu; L C Rump
Journal:  Internist (Berl)       Date:  2009-01       Impact factor: 0.743

5.  Captopril-enhanced renal scintigraphy in the diagnosis of pediatric hypertension.

Authors:  György Sandor Reusz; Eva Kis; Orsolya Cseprekál; Attila Jozsef Szabó; Eva Kis
Journal:  Pediatr Nephrol       Date:  2009-10-20       Impact factor: 3.714

6.  Renovascular hypertension associated with pseudoaneurysm following blunt trauma.

Authors:  Eric Judd; Mark E Lockhart; Dana V Rizk
Journal:  Am J Kidney Dis       Date:  2013-03-19       Impact factor: 8.860

7.  A randomized, multi-center, prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with hemodynamically relevant atherosclerotic renal artery stenosis (RADAR) - one-year results of a pre-maturely terminated study.

Authors:  Thomas Zeller; Hans Krankenberg; Andrejs Erglis; Erwin Blessing; Torsten Fuss; Dierk Scheinert; Ralf Weser; Beatrix B Doerr; Wilfrid D Yollo; Joerg Radermacher
Journal:  Trials       Date:  2017-08-14       Impact factor: 2.279

8.  Non-invasive Stenotic Renal Artery Haemodynamics by in silico Medicine.

Authors:  Aikaterini Mandaltsi; Andrii Grytsan; Aghogho Odudu; Jacek Kadziela; Paul D Morris; Adam Witkowski; Timothy Ellam; Philip Kalra; Alberto Marzo
Journal:  Front Physiol       Date:  2018-08-17       Impact factor: 4.566

9.  RADAR - A randomised, multi-centre, prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with haemodynamically relevant atherosclerotic renal artery stenosis.

Authors:  Uwe Schwarzwälder; Michael Hauk; Thomas Zeller
Journal:  Trials       Date:  2009-07-27       Impact factor: 2.279

10.  Renal Artery Stenting in Consecutive High-Risk Patients With Atherosclerotic Renovascular Disease: A Prospective 2-Center Cohort Study.

Authors:  Mark Reinhard; Karoline Schousboe; Ulrik B Andersen; Niels Henrik Buus; Jesper Moesgaard Rantanen; Jesper Nørgaard Bech; Hossein Mohit Mafi; Sten Langfeldt; Arindam Bharadwaz; Arne Hørlyck; Mogens Kærsgaard Jensen; Jørgen Jeppesen; Michael Hecht Olsen; Ib Abildgaard Jacobsen; Bo Martin Bibby; Kent Lodberg Christensen
Journal:  J Am Heart Assoc       Date:  2022-03-24       Impact factor: 6.106

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.